Invest Different
Results 81 - 90 of 516 : Previous 5 6 7 8 9 10 11 12 13 Next
This Just In: Upgrades and Downgrades
Street's prognosis for Celgene: Not good.
The Magic Formula for These Biotech Stocks
This mechanical strategy could be magic.
Here's How SuperGen Is Making You So Much Cash
All cash flow is not created equal.
Earnings Boost: 10 Takeover Targets With Excellent Growth Prospects
Do you think these companies make attractive acquisitions for your portfolio?
How Do These Biotechs Really Make Their Money?
Break it down using the Dupont formula.
Finding companies that have all the right stuff can produce winners.
An Undeserved Kick in the Pants
Celgene gets knocked around.
Which Stocks Have the Biggest Exposure to Aging Baby Boomers?
As baby boomers begin entering retirement, which stocks stand to profit from the shift?
Digging a little deeper into Gilead's acquisition of Arresto.
Why the Street Should Love Teva Pharmaceutical's Earnings
All cash flow is not created equal.
Results 81 - 90 of 516 : Previous 5 6 7 8 9 10 11 12 13 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK